Our data demonstrated that a novel anti‐DDR1 ADC potently and selectively killed DDR1‐positive colon cancer cells in vitro and eliminated the DDR1‐positive colon carcinoma in xenograft models. This evidence concerns the gene DDR1 and colonic neoplasm.